Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 145421, 8 pages
http://dx.doi.org/10.1155/2013/145421
Review Article

Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease

1Department of Pathophysiology and Transplantation (DEPT), Università degli Studi di Milano, Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Policlinico, 20122 Milano, Italy
2Division of Human Nutrition, Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi di Milano, 20122 Milano, Italy
3Pediatric Clinic 2, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Policlinico, 20122 Milano, Italy

Received 24 July 2013; Accepted 3 September 2013

Academic Editor: Cristina Angeloni

Copyright © 2013 Luca Valenti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Mensah, A. H. Mokdad, E. Ford et al., “Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications,” Cardiology Clinics, vol. 22, no. 4, pp. 485–504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Blachier, H. Leleu, M. Peck-Radosavljevic, D. C. Valla, and F. Roudot-Thoraval, “The burden of liver disease in Europe: a review of available epidemiological data,” Journal of Hepatology, vol. 58, no. 3, pp. 593–608, 2013. View at Publisher · View at Google Scholar
  3. R. Guerrero, G. L. Vega, S. M. Grundy, and J. D. Browning, “Ethnic differences in hepatic steatosis: an insulin resistance paradox?” Hepatology, vol. 49, no. 3, pp. 791–801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. WHO, Global Status Report on Non Communicable Diseases 2010, World Health Organization, Geneva, Switzerland, 2011.
  5. M. Cecchini, F. Sassi, J. A. Lauer, Y. Y. Lee, V. Guajardo-Barron, and D. Chisholm, “Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness,” The Lancet, vol. 376, no. 9754, pp. 1775–1784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Traka and R. F. Mithen, “Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals,” The Plant Cell, vol. 23, no. 7, pp. 2483–2497, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Bueno, P. Sáez-Plaza, F. Ramos-Escudero, A. M. Jiménez, R. Fett, and A. G. Asuero, “Analysis and antioxidant capacity of anthocyanin pigments. Part II: chemical structure, color, and intake of anthocyanins,” Critical Reviews in Analytical Chemistry, vol. 42, no. 2, pp. 126–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Castaneda-Ovando, M. de Lourdes Pacheco-Hernandez, M. E. Paez-Hernandez, J. A. Rodriguez C, and A. Galan-Vidal, “Chemical studies of anthocyanins: a review,” Food Chemistry, vol. 113, pp. 859–871, 2009. View at Publisher · View at Google Scholar
  9. J. Kühnau, “The flavonoids. A class of semi-essential food components: their role in human nutrition,” Nutrition, Metabolism and Cardiovascular Disease, vol. 24, pp. 117–120, 1976. View at Google Scholar
  10. M. G. L. Hertog, P. C. H. Hollman, M. B. Katan, and D. Kromhout, “Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands,” Nutrition and Cancer, vol. 20, no. 1, pp. 21–29, 1993. View at Google Scholar · View at Scopus
  11. X. Wu, G. R. Beecher, J. M. Holden, D. B. Haytowitz, S. E. Gebhardt, and R. L. Prior, “Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption,” Journal of Agricultural and Food Chemistry, vol. 54, no. 11, pp. 4069–4075, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Yang, S. I. Koo, W. O. Song, and O. K. Chun, “Food matrix affecting anthocyanin bioavailability: review,” Current Medicinal Chemistry, vol. 18, no. 2, pp. 291–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L.-S. Wang and G. D. Stoner, “Anthocyanins and their role in cancer prevention,” Cancer Letters, vol. 269, no. 2, pp. 281–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. D. del Rio, G. Borges, and A. Crozier, “Berry flavonoids and phenolics: bioavailability and evidence of protective effects,” British Journal of Nutrition, vol. 104, no. 3, pp. S67–S90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F.-F. Chong, R. MacDonald, and J. A. Lovegrove, “Fruit polyphenols and CVD risk: a review of human intervention studies,” British Journal of Nutrition, vol. 104, no. 3, pp. S28–S39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-M. Kong, L.-S. Chia, N.-K. Goh, T.-F. Chia, and R. Brouillard, “Analysis and biological activities of anthocyanins,” Phytochemistry, vol. 64, no. 5, pp. 923–933, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Galvano, L. La Fauci, G. Lazzarino et al., “Cyanidins: metabolism and biological properties,” Journal of Nutritional Biochemistry, vol. 15, no. 1, pp. 2–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Zafra-Stone, T. Yasmin, M. Bagchi, A. Chatterjee, J. A. Vinson, and D. Bagchi, “Berry anthocyanins as novel antioxidants in human health and disease prevention,” Molecular Nutrition and Food Research, vol. 51, no. 6, pp. 675–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. L. Prior and X. Wu, “Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities,” Free Radical Research, vol. 40, no. 10, pp. 1014–1028, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Sasaki, N. Nishimura, H. Hoshino et al., “Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice,” Biochemical Pharmacology, vol. 74, no. 11, pp. 1619–1627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Basu, M. Du, M. J. Leyva et al., “Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome,” Journal of Nutrition, vol. 140, no. 9, pp. 1582–1587, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. del Bo', A. S. Kristo, A. Z. Kalea et al., “The temporal effect of a wild blueberry (Vaccinium angustifolium)-enriched diet on vasomotor tone in the Sprague-Dawley rat,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 2, pp. 127–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Vendrame, A. Daugherty, A. S. Kristo, P. Riso, and D. Klimis-Zacas, “Wild blueberry (Vaccinium angustifolium) consumption improves inflammatory status in the obese Zucker rat model of the metabolic syndrome,” Journal of Nutritional Biochemistry, vol. 24, no. 8, pp. 1508–1512, 2013. View at Publisher · View at Google Scholar
  24. A. S. Kristo, A. Z. Kalea, D. A. Schuschke, and D. Klimis-Zacas, “Attenuation of alpha-adrenergic-induced vasoconstriction by dietary wild blueberries (Vaccinium angustifolium) is mediated by the NO-cGMP pathway in spontaneously hypertensive rats (SHRs),” International Journal of Food Science and Nutrition, 2013. View at Publisher · View at Google Scholar
  25. T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary cyanidin 3-O-β-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice,” Journal of Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003. View at Google Scholar · View at Scopus
  26. L. Titta, M. Trinei, M. Stendardo et al., “Blood orange juice inhibits fat accumulation in mice,” International Journal of Obesity, vol. 34, no. 3, pp. 578–588, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Vendrame, A. Daugherty, A. S. Kristo, and D. Klimis-Zacas, “Wild blueberry (Vaccinium angustifolium)-enriched diet improves dyslipidaemia and modulates the expression of genes related to lipid metabolism in obese Zucker rats,” British Journal of Nutrition, 2013. View at Publisher · View at Google Scholar
  28. G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001. View at Google Scholar · View at Scopus
  29. C. P. Day, “From fat to inflammation,” Gastroenterology, vol. 130, no. 1, pp. 207–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Bugianesi, N. Leone, E. Vanni et al., “Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma,” Gastroenterology, vol. 123, no. 1, pp. 134–140, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bellentani, G. Saccoccio, F. Masutti et al., “Prevalence of and risk factors for hepatic steatosis in northern Italy,” Annals of Internal Medicine, vol. 132, no. 2, pp. 112–117, 2000. View at Google Scholar · View at Scopus
  34. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Yamaguchi, L. Yang, S. McCall et al., “Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis,” Hepatology, vol. 45, no. 6, pp. 1366–1374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, “Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343–1351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Bugianesi, A. Gastaldelli, E. Vanni et al., “Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms,” Diabetologia, vol. 48, no. 4, pp. 634–642, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Marchesini, M. Brizi, A. M. Morselli-Labate et al., “Association of nonalcoholic fatty liver disease with insulin resistance,” American Journal of Medicine, vol. 107, no. 5, pp. 450–455, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Fabbrini, B. S. Mohammed, F. Magkos, K. M. Korenblat, B. W. Patterson, and S. Klein, “Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease,” Gastroenterology, vol. 134, no. 2, pp. 424–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Rametta, E. Mozzi, P. Dongiovanni et al., “Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects,” International Journal of Obesity, vol. 37, pp. 986–992, 2013. View at Publisher · View at Google Scholar
  41. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two “hits”?” Gastroenterology, vol. 114, no. 4 I, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Valenti, A. L. Fracanzani, and S. Fargion, “The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?” Seminars in Immunopathology, vol. 31, no. 3, pp. 359–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Miele, V. Valenza, G. La Torre et al., “Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease,” Hepatology, vol. 49, no. 6, pp. 1877–1887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. T. Bardella, L. Valenti, C. Pagliari et al., “Searching for coeliac disease in patients with non-alcoholic fatty liver disease,” Digestive and Liver Disease, vol. 36, no. 5, pp. 333–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Dongiovanni, Q. M. Anstee, and L. Valenti, “Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment,” Current Pharmaceutical Design, vol. 19, no. 29, pp. 5219–5238, 2013. View at Publisher · View at Google Scholar
  46. L. Valenti, A. Alisi, V. Nobili et al., “I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology,” Hepatology, vol. 56, no. 2, pp. 1883–1889, 2012. View at Google Scholar
  47. K. Valentová, J. Ulrichová, L. Cvak, and V. Šimánek, “Cytoprotective effect of a bilberry extract against oxidative damage of rat hepatocytes,” Food Chemistry, vol. 101, no. 3, pp. 912–917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Liu, D. Wang, D. Zhang et al., “Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro,” Journal of Agricultural and Food Chemistry, vol. 59, no. 22, pp. 12254–12263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. P. Hwang, J. H. Choi, E. H. Han et al., “Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice,” Nutrition Research, vol. 31, no. 12, pp. 896–906, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Guo, D. Li, W. Ling, X. Feng, and M. Xia, “Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKC ζ,” Journal of Lipid Research, vol. 52, no. 5, pp. 908–922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. B. O. Cho, H. W. Ryu, C. H. Jin et al., “Blackberry extract attenuates oxidative stress through up-regulation of Nrf2-dependent antioxidant enzymes in carbon tetrachloride-treated rats,” Journal of Agricultural and Food Chemistry, vol. 59, no. 21, pp. 11442–11448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Zhu, Q. Jia, Y. Wang, Y. Zhang, and M. Xia, “The anthocyanin cyanidin-3-O-β-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: involvement of a cAMP-PKA-dependent signaling pathway,” Free Radical Biology and Medicine, vol. 52, no. 2, pp. 314–327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Guo, G. Liu, R. Zhong, Y. Wang, D. Wang, and M. Xia, “Cyanidin-3-O-β-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells,” Lipids in Health and Disease, vol. 11, article 10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. J. J. Chang, M. J. Hsu, H. P. Huang et al., “Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance,” Journal of Agricultural and Food Chemistry, vol. 61, no. 25, pp. 6069–6076, 2013. View at Publisher · View at Google Scholar
  55. Y. Jia, J. Y. Kim, H. J. Jun et al., “Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid,” Biochimica et Biophysica Acta, vol. 1831, no. 4, pp. 698–708, 2013. View at Google Scholar
  56. J. Frank, A. Kamal-Eldin, T. Lundh, K. Määttä, R. Törrönen, and B. Vessby, “Effects of dietary anthocyanins on tocopherols and lipids in rats,” Journal of Agricultural and Food Chemistry, vol. 50, no. 25, pp. 7226–7230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Guo, M. Xia, T. Zou, W. Ling, R. Zhong, and W. Zhang, “Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1,” Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 349–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. E. M. Seymour, A. A. M. Singer, A. Kirakosyan, D. E. Urcuyo-Llanes, P. B. Kaufman, and S. F. Bolling, “Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator-activated receptors in rats with intake of tart cherry,” Journal of Medicinal Food, vol. 11, no. 2, pp. 252–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Takayama, K. Nakamoto, H. Kawasaki et al., “Beneficial effects of Vitis coignetiae Pulliat leaves on nonalcoholic steatohepatitis in a rat model,” Acta Medica Okayama, vol. 63, no. 2, pp. 105–111, 2009. View at Google Scholar · View at Scopus
  60. F. Salamone, G. Li Volti, L. Titta et al., “Moro orange juice prevents fatty liver in mice,” World Journal of Gastroenterology, vol. 18, no. 29, pp. 3862–3868, 2012. View at Publisher · View at Google Scholar
  61. E. M. Seymour, I. I. Tanone, D. E. Urcuyo-Llanes et al., “Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats,” Journal of Medicinal Food, vol. 14, no. 12, pp. 1511–1518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. C.-H. Peng, L.-K. Liu, C.-M. Chuang, C.-C. Chyau, C.-N. Huang, and C.-J. Wang, “Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis,” Journal of Agricultural and Food Chemistry, vol. 59, no. 6, pp. 2663–2671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Dubey, A. P. Jayasooriya, and S. K. Cheema, “Fish oil induced hyperlipidemia and oxidative stress in BioF1B hamsters is attenuated by elderberry extract,” Applied Physiology, Nutrition and Metabolism, vol. 37, no. 3, pp. 472–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Yang, L. Yang, and H. Zheng, “Hypolipidemic and antioxidant effects of mulberry (Morus alba L.) fruit in hyperlipidaemia rats,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2374–2379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Takikawa, S. Inoue, F. Horio, and T. Tsuda, “Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of amp-activated protein kinase in diabetic mice,” Journal of Nutrition, vol. 140, no. 3, pp. 527–533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. I. Suda, F. Ishikawa, M. Hatakeyama et al., “Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis,” European Journal of Clinical Nutrition, vol. 62, no. 1, pp. 60–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Nobili, G. Bedogni, A. Alisi et al., “Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial,” Archives of Disease in Childhood, vol. 96, no. 4, pp. 350–353, 2011. View at Publisher · View at Google Scholar · View at Scopus